Tumor-associated macrophages respond to chemotherapy by detrimental transcriptional reprogramming and suppressing stabilin-1 mediated clearance of EGF
IntroductionTumor resistance to chemotherapy and metastatic relapse account for more than 90% of cancer specific mortality. Tumor-associated macrophages (TAMs) can process chemotherapeutic agents and impair their action. Little is known about the direct effects of chemotherapy on TAMs.MethodsThe eff...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2023-03-01
|
| シリーズ: | Frontiers in Immunology |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1000497/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
